Budget Impact Analysis of Empagliflozin For The Treatment of Patients With Type 2 Diabetes Mellitus At Increased Cardiovascular Risk In Greece
Abstract
Authors
G Gourzoulidis C Tzanetakos I Ioannidis A Tsapas G Kourlaba G Papageorgiou N Maniadakis